3.23
price up icon0.94%   0.03
after-market Dopo l'orario di chiusura: 3.19 -0.04 -1.24%
loading
Precedente Chiudi:
$3.20
Aprire:
$3.21
Volume 24 ore:
429.02K
Relative Volume:
0.61
Capitalizzazione di mercato:
$320.35M
Reddito:
$69.56M
Utile/perdita netta:
$-240.05M
Rapporto P/E:
-1.0949
EPS:
-2.95
Flusso di cassa netto:
$-121.90M
1 W Prestazione:
+3.86%
1M Prestazione:
+13.33%
6M Prestazione:
+82.49%
1 anno Prestazione:
-13.40%
Intervallo 1D:
Value
$3.11
$3.24
Intervallo di 1 settimana:
Value
$2.98
$3.24
Portata 52W:
Value
$1.05
$3.98

Adc Therapeutics Sa Stock (ADCT) Company Profile

Name
Nome
Adc Therapeutics Sa
Name
Telefono
41 21 653 02 00
Name
Indirizzo
BIOPOLE, EPALINGES
Name
Dipendente
263
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-21
Name
Ultimi documenti SEC
Name
ADCT's Discussions on Twitter

Confronta ADCT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ADCT
Adc Therapeutics Sa
3.23 359.23M 69.56M -240.05M -121.90M -2.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-08 Iniziato Stephens Overweight
2024-05-30 Iniziato Cantor Fitzgerald Overweight
2024-03-28 Iniziato Guggenheim Buy
2023-08-10 Aggiornamento JP Morgan Underweight → Neutral
2023-04-24 Downgrade BofA Securities Neutral → Underperform
2022-12-06 Iniziato CapitalOne Overweight
2022-11-09 Downgrade BofA Securities Buy → Neutral
2022-09-21 Iniziato JP Morgan Overweight
2022-09-09 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-11-09 Iniziato Wolfe Research Outperform
2021-08-17 Ripresa Jefferies Buy
2021-08-09 Iniziato RBC Capital Mkts Outperform
2021-06-15 Iniziato Cantor Fitzgerald Overweight
2020-12-03 Iniziato Stifel Hold
2020-10-29 Iniziato H.C. Wainwright Buy
2020-06-09 Iniziato BofA/Merrill Buy
2020-06-09 Iniziato Cowen Outperform
Mostra tutto

Adc Therapeutics Sa Borsa (ADCT) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about ADC Therapeutics SA stockExceptional market performance - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Is ADC Therapeutics SA a good long term investmentAccelerated wealth building - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What drives ADC Therapeutics SA stock priceBreakout stock performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

ADC Therapeutics SA Stock Analysis and ForecastExplosive portfolio gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

ADC Therapeutics’ LOTIS-10 Study: A Potential Game-Changer in Lymphoma Treatment - TipRanks

Jul 16, 2025
pulisher
Jul 15, 2025

What makes ADC Therapeutics SA stock price move sharplyCapital Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why ADC Therapeutics SA stock attracts strong analyst attentionFree Market Sentiment Analysis - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How ADC Therapeutics SA stock performs during market volatilityFree Exclusive Stock Market Insights - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

ADC Therapeutics (NYSE:ADCT) Shares Down 4.2%What's Next? - MarketBeat

Jul 15, 2025
pulisher
Jul 14, 2025

Adc Therapeutics Sa shares fall 1.88% after-hours as Sonnet Biotherapeutics, Inc. announces $888 million funding. - AInvest

Jul 14, 2025
pulisher
Jul 12, 2025

ADC Therapeutics (NYSE:ADCT) Shares Down 4.2% – Here’s Why - Defense World

Jul 12, 2025
pulisher
Jul 05, 2025

ADC Therapeutics announces $100M private financing - MSN

Jul 05, 2025
pulisher
Jul 02, 2025

ADC Therapeutics Makes Grant to New Employee Under Inducement Plan - The Malaysian Reserve

Jul 02, 2025
pulisher
Jun 30, 2025

ADC Therapeutics (ADCT) Files Prospectus for Share Sale - GuruFocus

Jun 30, 2025
pulisher
Jun 30, 2025

ADCT SEC FilingsAdc Therapeutics Sa 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 30, 2025
pulisher
Jun 26, 2025

The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? - Weekly Voice

Jun 26, 2025
pulisher
Jun 24, 2025

ADC reports data from lymphoma trial, streamlines operations - MSN

Jun 24, 2025
pulisher
Jun 23, 2025

ADC Therapeutics (NYSE:ADCT) Stock Rating Upgraded by Royal Bank Of Canada - MarketBeat

Jun 23, 2025
pulisher
Jun 20, 2025

ADC Therapeutics (ADCT) Price Target Lowered by RBC Capital | AD - GuruFocus

Jun 20, 2025
pulisher
Jun 20, 2025

ADC Therapeutics price target lowered to $5 at RBC on growth outlook - Investing.com

Jun 20, 2025
pulisher
Jun 18, 2025

ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes - Quantisnow

Jun 18, 2025
pulisher
Jun 17, 2025

Adc Therapeutics SA (NYSE: ADCT) Continues Its Downward Trend - Stocksregister

Jun 17, 2025
pulisher
Jun 17, 2025

ADC Therapeutics Announces Updated ZYNLONTA Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma - marketscreener.com

Jun 17, 2025
pulisher
Jun 16, 2025

ZYNLONTA shows 85% response rate in marginal zone lymphoma trial By Investing.com - Investing.com Nigeria

Jun 16, 2025
pulisher
Jun 16, 2025

ZYNLONTA shows 85% response rate in marginal zone lymphoma trial - Investing.com Australia

Jun 16, 2025
pulisher
Jun 16, 2025

Breakthrough Lymphoma Treatment: ZYNLONTA Shows 85% Response Rate with 27-Month Durability in Latest Trial - Stock Titan

Jun 16, 2025
pulisher
Jun 16, 2025

Switzerland: ADC Therapeutics raises US$100m from PIPE financing - Investors in Healthcare

Jun 16, 2025
pulisher
Jun 15, 2025

Guggenheim Reaffirms Buy Rating for ADC Therapeutics (NYSE:ADCT) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

ADC Therapeutics (NYSE:ADCT) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Analysts Set Expectations for ADCT FY2026 Earnings - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Guggenheim Raises Price Target for ADC Therapeutics (ADCT) | ADCT Stock News - GuruFocus

Jun 14, 2025
pulisher
Jun 13, 2025

ADC Therapeutics (ADCT) Price Target Raised Amid Strategic Moves - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

ADC Therapeutics (ADCT) Secures $100M in PIPE Financing to Boost ZYNLONTA Development - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Layoff Tracker: ADC Therapeutics Cutting 30% of Staff, Closing London Research Facility - BioSpace

Jun 13, 2025

Adc Therapeutics Sa Azioni (ADCT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):